Better Therapeutics, Inc. - Common Stock (NQ:BTTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Better Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

November 14, 2022

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022

November 07, 2022

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer

October 27, 2022

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes ↗

September 22, 2022

Via Benzinga

Why Better Therapeutics Shares Are Surging During Premarket Session ↗

July 28, 2022

Via Benzinga

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market ↗

October 05, 2022

Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.

Via InvestorPlace

Positive Results from Pivotal Trial of Better Therapeutics’ Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care

October 04, 2022

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Submits De Novo Request to U.S. FDA for BT-001 Investigational Prescription Digital Therapy for Type 2 Diabetes

September 22, 2022

From Better Therapeutics, Inc.

Via Business Wire

Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

September 20, 2022

The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...

Via Benzinga

Bridgeline Digital And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

September 16, 2022

The Nasdaq 100 dropped by more than 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Better Therapeutics to Participate in Three Upcoming Investor Conferences

September 07, 2022

From Better Therapeutics

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

August 22, 2022

Good morning, investor! Let's get right into the biggest pre-market stock movers on Monday that traders will want to watch!

Via InvestorPlace

Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday ↗

August 23, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...

Via Benzinga

Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket ↗

August 22, 2022

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public...

Via Benzinga

Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 11, 2022

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics to Release Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022

August 04, 2022

From Better Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 02, 2022

Via Benzinga

Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday ↗

August 03, 2022

Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.

Via Benzinga

Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session ↗

August 02, 2022

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End of The Day Summary ↗

July 28, 2022

Via Benzinga

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗

August 02, 2022

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

Via Benzinga

This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗

July 29, 2022

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 28, 2022

Via Benzinga

Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session ↗

July 28, 2022

Gainers

Via Benzinga

Why Are Hydrogen Stocks PLUG, FCEL, BE Heating Up Today? ↗

July 28, 2022

Hydrogen stocks are climbing higher on Thursday thanks to news of Democrats reaching an agreement on climate change legislation.

Via InvestorPlace

Why Is Better Therapeutics (BTTX) Stock Up 27% Today? ↗

July 28, 2022

Better Therapeutics (BTTX) stock is rocketing higher on Thursday as investors react to results from a Phase 2 clinical trial.

Via InvestorPlace

Better Therapeutics' Shares Shoot Higher Following Positive Results From Type 2 Diabetes Study ↗

July 28, 2022

Better Therapeutics (NASDAQ: BTTX) announced positive results from its pivotal clinical trial for BT-001, prescription digital therapeutic that is designed to use nCBT to treat c diabetes (T2D).

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 28, 2022

Via Benzinga

Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results

July 28, 2022

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics to Host Conference Call to Review Results from Pivotal Clinical Trial of BT-001 for Type 2 Diabetes

July 26, 2022

From Better Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.